Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania

Abstract Background Tuberculosis (TB) is the leading cause of death from an infectious disease and the roll-out of rapid molecular diagnostics for rifampin resistance has resulted in a steady rise in the number of patients with multidrug-resistant (MDR)-TB referred for treatment. Pyrazinamide is use...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Saumu Pazia Juma, Athanasia Maro, Suporn Pholwat, Stellah G. Mpagama, Jean Gratz, Alphonse Liyoyo, Eric R. Houpt, Gibson S. Kibiki, Blandina T. Mmbaga, Scott K. Heysell
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2019-02-01
Edice:	BMC Infectious Diseases
On-line přístup:	http://link.springer.com/article/10.1186/s12879-019-3757-1
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!